bezafibrate has been researched along with dinoprost in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Buytenhek, R; de Man, FH; Jonkers, IJ; Leuven, JA; Onkenhout, W; Princen, HM; Schwedhelm, E; Smelt, AH; Troost, R; van Der Laarse, A; van Duyvenvoorde, W | 1 |
1 trial(s) available for bezafibrate and dinoprost
| Article | Year |
|---|---|
Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy.
Topics: Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Dinoprost; Double-Blind Method; Female; Humans; Hypertriglyceridemia; In Vitro Techniques; Lipid Metabolism; Lipids; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress | 2000 |
1 other study(ies) available for bezafibrate and dinoprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |